HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The identification of miRNA and mRNA expression profiles associated with pediatric atypical teratoid/rhabdoid tumor.

AbstractBACKGROUND:
Atypical teratoid/rhabdoid tumor (AT/RT) is a malignant pediatric tumor of the central nervous system (CNS) with high recurrence and low survival rates that is often misdiagnosed. MicroRNAs (miRNAs) are involved in the tumorigenesis of numerous pediatric cancers, but their roles in AT/RT remain unclear.
METHODS:
In this study, we used miRNA sequencing and gene expression microarrays from patient tissue to study both the miRNAome and transcriptome traits of AT/RT.
RESULTS:
Our findings demonstrate that 5 miRNAs were up-regulated, 16 miRNAs were down-regulated, 179 mRNAs were up-regulated and 402 mRNAs were down-regulated in AT/RT. qPCR revealed that hsa-miR-17-5p and MAP7 mRNA were the most significantly differentially expressed miRNA and mRNA in AT/RT tissues. Furthermore, the results from analyses using the miRTarBase database identified MAP7 mRNA as a target gene of hsa-miR-17-5p.
CONCLUSIONS:
Our findings suggest that the dysregulation of hsa-miR-17-5p may be a pivotal event in AT/RT and miRNAs that may represent potential therapeutic targets and diagnostic biomarkers.
AuthorsXinke Xu, Hongyao Yuan, Junping Pan, Wei Chen, Cheng Chen, Yang Li, Fangcheng Li
JournalBMC cancer (BMC Cancer) Vol. 22 Issue 1 Pg. 499 (May 06 2022) ISSN: 1471-2407 [Electronic] England
PMID35524230 (Publication Type: Journal Article)
Copyright© 2022. The Author(s).
Chemical References
  • MicroRNAs
  • RNA, Messenger
Topics
  • Central Nervous System Neoplasms (genetics)
  • Child
  • Gene Expression Profiling
  • Gene Regulatory Networks
  • Humans
  • MicroRNAs (genetics, metabolism)
  • RNA, Messenger (genetics)
  • Rhabdoid Tumor (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: